糖尿病作为局部晚期直肠癌的预后因素。
Diabetes Mellitus as a Prognostic Factor for Locally Advanced Rectal Cancer.
机构信息
Department of General Surgery, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Department of General Surgery, "Dr. Ion Cantacuzino" Clinical Hospital, Bucharest, Romania.
出版信息
In Vivo. 2021 Jul-Aug;35(4):2495-2501. doi: 10.21873/invivo.12530.
Abstract
BACKGROUND/AIM: Currently, the impact of diabetes mellitus (DM) on rectal cancer patients is complex and just partly elucidated. The purpose of this study was to investigate the impact of diabetes mellitus on rectal cancer patients focusing on tumor differentiation grade, neoadjuvant chemoradiotherapy (NACRT) response, disease-free (DFS) and overall (OS) survival.
PATIENTS AND METHODS
Our study's population consisted of a group of 53 patients diagnosed with locally advanced rectal cancer, who underwent NACRT, followed by radical oncological surgery. This patient population was further divided into two groups according to diabetes presence.
RESULTS
Downstaging rates, local control, DFS, and OS were lower in the DM subgroup compared to the non-DM locally advanced rectal cancer patients.
CONCLUSION
The presence of DM at the time of diagnosis of locally advanced rectal cancer patients may be a negative predictive factor for response to neoadjuvant therapy, distant metastases, and local recurrences rates.
摘要
背景/目的：目前，糖尿病（DM）对直肠癌患者的影响较为复杂，部分原因尚未阐明。本研究旨在探讨糖尿病对直肠癌患者的影响，重点关注肿瘤分化程度、新辅助放化疗（NACRT）反应、无病生存（DFS）和总生存（OS）。
患者和方法
我们的研究人群由一组 53 名诊断为局部晚期直肠癌的患者组成，这些患者接受了 NACRT，随后进行了根治性肿瘤手术。根据是否存在糖尿病，将这组患者进一步分为两组。
结果
DM 亚组的降期率、局部控制率、DFS 和 OS 均低于非 DM 局部晚期直肠癌患者。
结论
在诊断局部晚期直肠癌患者时存在 DM 可能是对新辅助治疗、远处转移和局部复发率反应的负面预测因素。
相似文献
1
Diabetes Mellitus as a Prognostic Factor for Locally Advanced Rectal Cancer.糖尿病作为局部晚期直肠癌的预后因素。
In Vivo. 2021 Jul-Aug;35(4):2495-2501. doi: 10.21873/invivo.12530.
2
Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.新辅助放化疗后肿瘤退缩分级对一组局部晚期直肠癌患者的预后意义：一项为期8年的单机构回顾性研究。
Colorectal Dis. 2017 Jul;19(7):O263-O271. doi: 10.1111/codi.13757.
3
Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.新辅助放化疗可能为局部晚期Ⅲb/Ⅲc期直肠癌患者带来生存获益：一项单机构回顾性研究及倾向评分匹配比较分析
Asia Pac J Clin Oncol. 2020 Jun;16(3):142-149. doi: 10.1111/ajco.13306. Epub 2020 Feb 7.
4
Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.新辅助放化疗和全直肠系膜切除术治疗后，Ⅱ期或Ⅲ期直肠癌患者辅助化疗并不能改善无复发生存。
Dis Colon Rectum. 2020 Apr;63(4):427-440. doi: 10.1097/DCR.0000000000001558.
5
Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.新辅助直肠评分及其他生物标志物对接受新辅助放化疗的局部进展期直肠癌香港华人患者临床结局的预后意义。
Hong Kong Med J. 2022 Jun;28(3):230-238. doi: 10.12809/hkmj208969. Epub 2022 Jun 7.
6
Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.新辅助放化疗联合根治性手术后达到病理完全缓解的局部晚期直肠癌患者是否需要辅助化疗？单中心40例ypCR患者的长期分析
Int J Colorectal Dis. 2016 Jun;31(6):1163-8. doi: 10.1007/s00384-016-2579-5. Epub 2016 Apr 5.
7
Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.新辅助放化疗后局部晚期直肠癌达到最佳无复发生存的时间：中国大样本量中心的经验。
Int J Colorectal Dis. 2021 May;36(5):1007-1016. doi: 10.1007/s00384-020-03829-y. Epub 2021 Jan 4.
8
Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.新辅助同步放化疗改善直肠癌肿瘤反应，增加二甲双胍的生存获益。
Dis Colon Rectum. 2020 Jun;63(6):758-768. doi: 10.1097/DCR.0000000000001624.
9
Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.新辅助放化疗后局部晚期直肠癌患者转移性淋巴结退缩分级的预后价值。
Surgery. 2019 Dec;166(6):1061-1067. doi: 10.1016/j.surg.2019.06.009. Epub 2019 Jul 23.
10
Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.新辅助直肠评分在局部进展期直肠癌术前短程放疗和长程同期放化疗中的预后意义。
Ann Surg Oncol. 2020 Oct;27(11):4309-4318. doi: 10.1245/s10434-020-09018-z. Epub 2020 Aug 13.
引用本文的文献
1
KRAS Mutation Status in Relation to Clinicopathological Characteristics of Romanian Colorectal Cancer Patients.KRAS突变状态与罗马尼亚结直肠癌患者临床病理特征的关系
Curr Issues Mol Biol. 2025 Feb 12;47(2):120. doi: 10.3390/cimb47020120.
2
Effect of Diabetes on Outcomes in Patients With Incurable/Unresectable and Advanced/Recurrent Colorectal Cancer Receiving mFOLFOX6.糖尿病对接受mFOLFOX6治疗的不可治愈/不可切除及晚期/复发性结直肠癌患者预后的影响。
Cancer Diagn Progn. 2025 Jan 3;5(1):42-48. doi: 10.21873/cdp.10410. eCollection 2025 Jan-Feb.
3
The Characteristics of Sentinel Lymph Node Biopsy in Cutaneous Melanoma and the Particularities for Elderly Patients-Experience of a Single Clinic.皮肤黑色素瘤前哨淋巴结活检的特点及老年患者的特殊性——单中心经验
Diagnostics (Basel). 2023 Mar 1;13(5):926. doi: 10.3390/diagnostics13050926.
4
Sentinel Lymph Node Detection with Indocyanine Green in Colorectal Cancer.吲哚菁绿在结直肠癌前哨淋巴结检测中的应用
Maedica (Bucur). 2022 Jun;17(2):264-270. doi: 10.26574/maedica.2022.17.2.264.
5
Blood Group Type Association with Head and Neck Cancer.血型与头颈癌的关联。
Hematol Rep. 2022 Mar 2;14(1):24-30. doi: 10.3390/hematolrep14010005.
本文引用的文献
1
When Should We Expect Curative Results of Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients?局部晚期直肠癌患者新辅助治疗的治愈效果何时可期？
Chirurgia (Bucur). 2021 Jan-Feb;116(1):16-23. doi: 10.21614/chirurgia.116.1.16.
2
Changing the Prognosis of Metastatic Cervix Uteri Adenosquamous Carcinoma through a Multimodal Approach: A Case Report.通过多模式方法改变转移性子宫颈腺鳞癌的预后：一例报告
Case Rep Oncol. 2020 Dec 23;13(3):1545-1551. doi: 10.1159/000511564. eCollection 2020 Sep-Dec.
3
The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses.与正常直肠组织相比，直肠癌组织中的蛋白质分泌组发生了改变，且分泌组的改变会诱导增强的固有免疫反应。
Cancers (Basel). 2021 Feb 2;13(3):571. doi: 10.3390/cancers13030571.
4
Quality of Life in Patients with Surgically Removed Skin Tumors.皮肤肿瘤切除术后患者的生活质量。
Medicina (Kaunas). 2020 Feb 9;56(2):66. doi: 10.3390/medicina56020066.
5
Diabetes Mellitus as a Risk-factor for Colorectal Cancer Literature Review - Current Situation and Future Perspectives.
Chirurgia (Bucur). 2018 Sept-Oct;113(5):603-610. doi: 10.21614/chirurgia.113.5.603.
6
High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events.宫颈癌中高剂量率 tandem 和 ovoid 近距离放疗：不良事件的剂量学预测因素。
Radiat Oncol. 2018 Jul 16;13(1):129. doi: 10.1186/s13014-018-1074-2.
7
Synchronous Locally Advanced Rectal Cancer with Clinical Complete Remission and Important Downstaging after Neoadjuvant Radiochemotherapy - Personalised Therapeutic Approach.同步局部进展期直肠癌经新辅助放化疗后达到临床完全缓解且肿瘤显著降期——个体化治疗方法
Chirurgia (Bucur). 2017 Nov-Dec;112(6):726-733. doi: 10.21614/chirurgia.112.6.726.
8
Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis.患有糖尿病的结直肠癌患者死亡率增加：一项更新的荟萃分析。
Oncotarget. 2017 Aug 4;8(37):62478-62488. doi: 10.18632/oncotarget.19923. eCollection 2017 Sep 22.
9
Men's information-seeking behavior regarding cancer risk and screening: A meta-narrative systematic review.男性对癌症风险和筛查的信息寻求行为：一项元叙述性系统评价。
Psychooncology. 2018 Feb;27(2):410-419. doi: 10.1002/pon.4506. Epub 2017 Aug 18.
10
Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity.直肠癌的超分割加速再照射：疗效与毒性分析
Radiother Oncol. 2017 Jan;122(1):146-151. doi: 10.1016/j.radonc.2016.12.015. Epub 2017 Jan 3.
Zotero 插件